Gilead Sciences, Inc.
Gilead Sciences, Inc.
333 Lakeside Drive
Foster City, CA 94404
(650) 574-3000Website: https://www.gilead.com/Careers: https://www.gilead.com/careersPatient Assistance Program: https://www.gilead.com/responsibility...
Latest News
- FDA Approves Veklury (remdesivir) for the Treatment of Non-Hospitalized Patients at High Risk for COVID-19 Disease Progression - January 21, 2022
- Gilead Announces Clinical Hold on Studies Evaluating Injectable Lenacapavir for HIV Treatment and Prevention Due to Vial Quality Concerns - December 21, 2021
- Gilead Submits Biologics License Application to U.S. Food and Drug Administration for Bulevirtide, an Investigational Treatment for People Living With Chronic Hepatitis Delta - November 19, 2021
- U.S. Food and Drug Administration Approves Expanded Indication of Gilead’s Biktarvy for Treatment of HIV-1 in Pediatric Populations - October 18, 2021
- Veklury (remdesivir) Significantly Reduced Risk of Hospitalization in High-Risk Patients with COVID-19 - September 22, 2021
- New Phase 3 Data Support the Sustained, Long-Acting Efficacy of Lenacapavir, Gilead's Investigational HIV-1 Capsid Inhibitor - July 17, 2021
- Gilead Submits New Drug Application to U.S. Food and Drug Administration for Lenacapavir, an Investigational, Long-Acting Capsid Inhibitor for the Treatment of HIV-1 in People With Limited Therapy Options - June 28, 2021
- Treatment With Hepcludex (bulevirtide) Was Shown to Achieve Significant Response in Chronic Hepatitis Delta Virus After 24 Weeks - June 24, 2021
- U.S. Food and Drug Administration Approves New Formulation of Epclusa, Expanding Pediatric Indication to Treat Children Ages 3 and Older With Chronic Hepatitis C - June 10, 2021
- Gilead and Merck Announce Agreement to Jointly Develop and Commercialize Long-Acting, Investigational Treatment Combinations of Lenacapavir and Islatravir in HIV - March 15, 2021
Drugs Associated with Gilead Sciences, Inc.
Gilead Sciences, Inc. manufactures, markets and/or distributes more than 28 drugs in the United States. Medications listed here may also be marketed under different names in different countries. Non-US country and region specific information is not available on this page.
| Brand/Generic Name | Reviews | Rating |
|---|---|---|
|
AmBisome
Generic name: amphotericin b liposomal Drug class: polyenes |
||
|
Atripla
Generic name: efavirenz/emtricitabine/tenofovir Drug class: antiviral combinations |
98 reviews | 9.0 / 10 |
|
Biktarvy
Generic name: bictegravir/emtricitabine/tenofovir alafenamide Drug class: antiviral combinations |
139 reviews | 7.1 / 10 |
|
Cayston
Generic name: aztreonam Drug class: miscellaneous antibiotics |
||
|
Complera
Generic name: emtricitabine/rilpivirine/tenofovir Drug class: antiviral combinations |
51 reviews | 8.4 / 10 |
|
Descovy
Generic name: emtricitabine/tenofovir alafenamide Drug class: antiviral combinations |
7 reviews | 5.7 / 10 |
|
Emtriva
Generic name: emtricitabine Drug class: nucleoside reverse transcriptase inhibitors (NRTIs) |
||
|
Epclusa
Generic name: sofosbuvir/velpatasvir Drug class: antiviral combinations |
230 reviews | 8.0 / 10 |
|
Genvoya
Generic name: cobicistat/elvitegravir/emtricitabine/tenofovir alafenamide Drug class: antiviral combinations |
109 reviews | 7.2 / 10 |
|
Harvoni
Generic name: ledipasvir/sofosbuvir Drug class: antiviral combinations |
334 reviews | 8.6 / 10 |
|
Hepsera
Generic name: adefovir Drug class: nucleoside reverse transcriptase inhibitors (NRTIs) |
||
|
Letairis
Generic name: ambrisentan Drug class: agents for pulmonary hypertension |
9 reviews | 8.8 / 10 |
|
Lexiscan
Generic name: regadenoson Drug class: cardiac stressing agents |
25 reviews | 5.1 / 10 |
|
Macugen
Generic name: pegaptanib Drug class: anti-angiogenic ophthalmic agents |
1 review | 9.0 / 10 |
|
Odefsey
Generic name: emtricitabine/rilpivirine/tenofovir alafenamide Drug class: antiviral combinations |
8 reviews | 8.0 / 10 |
|
Ranexa
Generic name: ranolazine Drug class: antianginal agents |
58 reviews | 7.2 / 10 |
|
Sovaldi
Generic name: sofosbuvir Drug class: miscellaneous antivirals |
42 reviews | 7.7 / 10 |
|
Stribild
Generic name: cobicistat/elvitegravir/emtricitabine/tenofovir Drug class: antiviral combinations |
81 reviews | 9.5 / 10 |
|
Tamiflu
Generic name: oseltamivir Drug class: neuraminidase inhibitors |
510 reviews | 6.0 / 10 |
|
Tecartus
Generic name: brexucabtagene autoleucel Drug class: miscellaneous antineoplastics |
||
|
Truvada
Generic name: emtricitabine/tenofovir Drug class: antiviral combinations |
28 reviews | 6.4 / 10 |
|
Tybost
Generic name: cobicistat Drug class: antiviral boosters |
||
|
Veklury
Generic name: remdesivir Drug class: investigational drugs, purine nucleosides |
||
|
Vemlidy
Generic name: tenofovir alafenamide Drug class: nucleoside reverse transcriptase inhibitors (NRTIs) |
1 review | 8.0 / 10 |
|
Viread
Generic name: tenofovir Drug class: nucleoside reverse transcriptase inhibitors (NRTIs) |
10 reviews | 8.0 / 10 |
|
Vosevi
Generic name: sofosbuvir/velpatasvir/voxilaprevir Drug class: antiviral combinations |
||
|
Yescarta
Generic name: axicabtagene ciloleucel Drug class: miscellaneous antineoplastics |
||
|
Zydelig
Generic name: idelalisib Drug class: PI3K inhibitors |
1 review | 1.0 / 10 |
| For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective). | ||